Compare Cipta Sarana Medika Tbk. (DKHH) vs Intanwijaya Internasional Tbk (INCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Intanwijaya Internasional Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B), while Intanwijaya Internasional Tbk trades at Rp645 (market cap 133.94B). The key difference: Cipta Sarana Medika Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| DKHH | INCI | |
|---|---|---|
Market Cap | 160.67B | 133.94B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Intanwijaya Internasional Tbk
PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.
Read more on INCI →
